What drugs does Y-MABS THERAPEUTICS INC make?

Y-MABS THERAPEUTICS INC has 1 FDA-approved drugs.

What therapeutic areas does Y-MABS THERAPEUTICS INC focus on?

Y-MABS THERAPEUTICS INC focuses primarily on Immunology and Oncology and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

Y-MABS THERAPEUTICS INC

ImmunologyOncologyDermatology

Biotech

Y-MABS THERAPEUTICS INC is a biotechnology company focused on Immunology, Oncology, Dermatology.

2020

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 81%

0 drugs Phase 3: 5 Phase 2: 3

Oncology 13%

0 drugs Phase 1: 4

Dermatology 6%

0 drugs Phase 2: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Oncology, Dermatology, Immunology

Eli Lilly big-pharma

Oncology, Immunology, Dermatology

COSETTE other

Dermatology, Immunology, Oncology

Y-MABS THERAPEUTICS INC

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info